| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
690 |
684 |
$103K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
496 |
496 |
$71K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
423 |
420 |
$64K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
156 |
154 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
101 |
98 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,039 |
1,030 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
35 |
35 |
$5K |
| S9083 |
Global fee urgent care centers |
20 |
19 |
$3K |
| 81002 |
|
66 |
66 |
$154.69 |
| 87807 |
|
17 |
17 |
$147.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
107 |
106 |
$9.92 |
| A9150 |
Non-prescription drugs |
14 |
14 |
$0.00 |
| 0011A |
|
43 |
42 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
21 |
$0.00 |
| 0012A |
|
39 |
39 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
55 |
55 |
$0.00 |
| 81025 |
|
22 |
22 |
$0.00 |